Connect
Comment receiving replies
I discovered in the first of August that I had breast cancer ( IDC) and They decided to do a mastectomy on the first of October. But until now I have not decided the neoadjuvant therapy because they decided that they should do the Oncotype lately. After the operation, they discovered that it was 2 mm in size, so they told me I have to start the hormone therapy after month from the surgery But when I interviewed the Oncologyest, the plan changed and she told me that the tumor size was 8 mm and not 2 mm because they forgot to calculate the size of the biopsy with the size of the remaining tumor so that the result was 8 mm. And she asked me to do the Oncotype test and the result was 20.do you think I need chemotherapy or just Harmon therapy
HER 2NEU negative
PT1b
PN0
The biopsy gave the grade is 1 but the residual tumor gave the grade is 2.
ER 86.99% strong positive
PR 64.99% strong positive
The genetic test is negative
Replies to "I discovered in the first of August that I had breast cancer ( IDC) and They..."
Connect
Look up the TailorX study.
TAILORx results published in June 2018 found that most women with a Recurrence Score of 11 to 25 also could safely skip chemotherapy. The TAILORx study included 10,273 women diagnosed with hormone-receptor-positive, HER2-negative breast cancer that had not spread to the lymph nodes.
TAILORx Data Suggest Race Can Affect Breast Cancer Outcomes